CD274 and neoplasm: Briefly, histology type, PD-L1 expression of pre-NCIO, pembrolizumab/nab-paclitaxel–based regimens, tumor size of post-NICO, tumor regression rate, ORR, max of standardized uptake value (SUVmax) of tumor post-NCIO, △SUVmax rate (SUVmax reduced rate) of tumor post-NICO were commonly associated with the pCR and MPR rates (all P < 0.05).